Literature DB >> 20054869

Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.

Eugene Bolotin1, Hailing Liao, Tuong Chi Ta, Chuhu Yang, Wendy Hwang-Verslues, Jane R Evans, Tao Jiang, Frances M Sladek.   

Abstract

UNLABELLED: Hepatocyte nuclear factor 4 alpha (HNF4alpha), a member of the nuclear receptor superfamily, is essential for liver function and is linked to several diseases including diabetes, hemophilia, atherosclerosis, and hepatitis. Although many DNA response elements and target genes have been identified for HNF4alpha, the complete repertoire of binding sites and target genes in the human genome is unknown. Here, we adapt protein binding microarrays (PBMs) to examine the DNA-binding characteristics of two HNF4alpha species (rat and human) and isoforms (HNF4alpha2 and HNF4alpha8) in a high-throughput fashion. We identified approximately 1400 new binding sequences and used this dataset to successfully train a Support Vector Machine (SVM) model that predicts an additional approximately 10,000 unique HNF4alpha-binding sequences; we also identify new rules for HNF4alpha DNA binding. We performed expression profiling of an HNF4alpha RNA interference knockdown in HepG2 cells and compared the results to a search of the promoters of all human genes with the PBM and SVM models, as well as published genome-wide location analysis. Using this integrated approach, we identified approximately 240 new direct HNF4alpha human target genes, including new functional categories of genes not typically associated with HNF4alpha, such as cell cycle, immune function, apoptosis, stress response, and other cancer-related genes.
CONCLUSION: We report the first use of PBMs with a full-length liver-enriched transcription factor and greatly expand the repertoire of HNF4alpha-binding sequences and target genes, thereby identifying new functions for HNF4alpha. We also establish a web-based tool, HNF4 Motif Finder, that can be used to identify potential HNF4alpha-binding sites in any sequence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20054869      PMCID: PMC3581146          DOI: 10.1002/hep.23357

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

1.  Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays.

Authors:  Alvaro Rada-Iglesias; Ola Wallerman; Christoph Koch; Adam Ameur; Stefan Enroth; Gayle Clelland; Kenneth Wester; Sarah Wilcox; Oliver M Dovey; Peter D Ellis; Vicki L Wraight; Keith James; Rob Andrews; Cordelia Langford; Pawandeep Dhami; Nigel Carter; David Vetrie; Fredrik Pontén; Jan Komorowski; Ian Dunham; Claes Wadelius
Journal:  Hum Mol Genet       Date:  2005-10-12       Impact factor: 6.150

Review 2.  Analysis of sequence specificities of DNA-binding proteins with protein binding microarrays.

Authors:  Martha L Bulyk
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

Review 3.  Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays.

Authors:  Peter C Scacheri; Gregory E Crawford; Sean Davis
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

4.  Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.

Authors:  Sian Ellard; Kevin Colclough
Journal:  Hum Mutat       Date:  2006-09       Impact factor: 4.878

5.  Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.

Authors:  T Tanaka; S Jiang; H Hotta; K Takano; H Iwanari; K Sumi; K Daigo; R Ohashi; M Sugai; C Ikegame; H Umezu; Y Hirayama; Y Midorikawa; Y Hippo; A Watanabe; Y Uchiyama; G Hasegawa; Pc Reid; H Aburatani; T Hamakubo; J Sakai; M Naito; T Kodama
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

6.  Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters.

Authors:  Chuhu Yang; Eugene Bolotin; Tao Jiang; Frances M Sladek; Ernest Martinez
Journal:  Gene       Date:  2006-10-10       Impact factor: 3.688

Review 7.  HNF-4alpha: from MODY to late-onset type 2 diabetes.

Authors:  Rana K Gupta; Klaus H Kaestner
Journal:  Trends Mol Med       Date:  2004-11       Impact factor: 11.951

8.  Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Authors:  Wendy W Hwang-Verslues; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2007-09-20

9.  Spatial normalization of array-CGH data.

Authors:  Pierre Neuvial; Philippe Hupé; Isabel Brito; Stéphane Liva; Elodie Manié; Caroline Brennetot; François Radvanyi; Alain Aurias; Emmanuel Barillot
Journal:  BMC Bioinformatics       Date:  2006-05-22       Impact factor: 3.169

10.  Core transcriptional regulatory circuitry in human hepatocytes.

Authors:  Duncan T Odom; Robin D Dowell; Elizabeth S Jacobsen; Lena Nekludova; P Alexander Rolfe; Timothy W Danford; David K Gifford; Ernest Fraenkel; Graeme I Bell; Richard A Young
Journal:  Mol Syst Biol       Date:  2006-05-02       Impact factor: 11.429

View more
  103 in total

1.  An epistatic mini-circuitry between the transcription factors Snail and HNF4α controls liver stem cell and hepatocyte features exhorting opposite regulation on stemness-inhibiting microRNAs.

Authors:  F Garibaldi; C Cicchini; A Conigliaro; L Santangelo; A M Cozzolino; G Grassi; A Marchetti; M Tripodi; L Amicone
Journal:  Cell Death Differ       Date:  2011-12-02       Impact factor: 15.828

2.  Disease allele-dependent small-molecule sensitivities in blood cells from monogenic diabetes.

Authors:  Stanley Y Shaw; David M Blodgett; Maggie S Ma; Elizabeth C Westly; Paul A Clemons; Aravind Subramanian; Stuart L Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-23       Impact factor: 11.205

3.  Src tyrosine kinase phosphorylation of nuclear receptor HNF4α correlates with isoform-specific loss of HNF4α in human colon cancer.

Authors:  Karthikeyani Chellappa; Lucy Jankova; Jake M Schnabl; Songqin Pan; Yann Brelivet; Caroline L-S Fung; Charles Chan; Owen F Dent; Stephen J Clarke; Graham R Robertson; Frances M Sladek
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 4.  Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.

Authors:  Pooja Chaudhari; Lipeng Tian; Abhijeet Deshmukh; Yoon-Young Jang
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-06

Review 5.  ABCC6 as a target in pseudoxanthoma elasticum.

Authors:  András Váradi; Zalán Szabó; Viola Pomozi; Hugues de Boussac; Krisztina Fülöp; Tamás Arányi
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

6.  Modification in oxidative stress, inflammation, and lipoprotein assembly in response to hepatocyte nuclear factor 4alpha knockdown in intestinal epithelial cells.

Authors:  Valérie Marcil; Ernest Seidman; Daniel Sinnett; François Boudreau; Fernand-Pierre Gendron; Jean-François Beaulieu; Daniel Ménard; Louis-Philippe Precourt; Devendra Amre; Emile Levy
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

7.  ErbB3-binding protein 1 (EBP1) represses HNF4α-mediated transcription and insulin secretion in pancreatic β-cells.

Authors:  Eun Hee Han; Puja Singh; In-Kyu Lee; Raul Urrutia; Young-In Chi
Journal:  J Biol Chem       Date:  2019-07-30       Impact factor: 5.157

8.  Opposing roles of nuclear receptor HNF4α isoforms in colitis and colitis-associated colon cancer.

Authors:  Karthikeyani Chellappa; Poonamjot Deol; Jane R Evans; Linh M Vuong; Gang Chen; Nadege Briançon; Eugene Bolotin; Christian Lytle; Meera G Nair; Frances M Sladek
Journal:  Elife       Date:  2016-05-11       Impact factor: 8.140

9.  Hepatocyte nuclear factor 4α and downstream secreted phospholipase A2 GXIIB regulate production of infectious hepatitis C virus.

Authors:  Xinlei Li; Hanfang Jiang; Linbing Qu; Wenxia Yao; Hua Cai; Ling Chen; Tao Peng
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

10.  HNF4α antagonists discovered by a high-throughput screen for modulators of the human insulin promoter.

Authors:  Alice Kiselyuk; Seung-Hee Lee; Suzette Farber-Katz; Mingjun Zhang; Sonalee Athavankar; Tom Cohen; Anthony B Pinkerton; Mao Ye; Paul Bushway; Adam D Richardson; Heather A Hostetler; Mariam Rodriguez-Lee; Li Huang; Benjamin Spangler; Layton Smith; Jennifer Higginbotham; John Cashman; Hudson Freeze; Pamela Itkin-Ansari; Marcia I Dawson; Friedhelm Schroeder; Yong Cang; Mark Mercola; Fred Levine
Journal:  Chem Biol       Date:  2012-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.